Expectant mothers might not need to worry about a glass of wine, according to new research published in Obstetrics & Gynecology.
Expectant mothers might not need to worry about a glass of wine, according to new research published in Obstetrics & Gynecology.
Researchers at Cork University Maternity Hospital studied data from 5628 nulliparous pregnant participants, who had been recruited to a prospective cohort study, the Screening for Pregnancy Endpoints study. The women were interviewed at 15 weeks’ gestation and submitted a questionnaire about their alcohol intake before and during the pregnancy.
Occasional alcohol consumption-1 to 2 alcohol units per week-was reported by 1090 (19%) of the participants and low alcohol consumption-3 to 7 units per week-was reported by 1383 (25%) of women. Three hundred (5%) reported heavy alcohol consumption (>14 units per week). Roughly a third of the participants (n = 1905) reported binge consumption, meaning drinking 6 or more alcohol units in one sitting, in the 3 months prior to pregnancy and 23% (n = 1288) indicated that they had binged on alcohol at some point during the first 15 weeks of pregnancy.
Altered odds for small-for-gestational age infant, reduced birth weight, preeclampsia, or spontaneous preterm delivery were not seen in women who consumed alcohol during early pregnancy, even those who reported heavy or binge consumption. The study’s authors stressed that although no adverse effects were seen in the study, no level of alcohol consumption during pregnancy is proven safe.
What do you think of this study? Will you be using it to reassure patients who consumed alcohol before discovering their pregnancy? Alternatively, do you find that these sorts of studies only confuse your patients?
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary Ob/Gyn Special Delivery.
Removing parental consent reduces delays in adolescent abortion care
February 12th 2025A new study links the removal of parental consent requirements for abortion in Massachusetts to significantly earlier gestational age at the time of the procedure, highlighting the impact of reduced barriers on timely reproductive care.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Variations reported in state-level maternal death causes
February 11th 2025A recent study highlights significant variations in pregnancy-related deaths across US states, emphasizing the need for targeted policies to address homicide, suicide, and drug overdose among pregnant and postpartum individuals.
Read More
Deep dive into fetal ventriculomegaly
February 10th 2025Fetal ventriculomegaly, a condition marked by the dilation of cerebral ventricles, is a common finding on second-trimester ultrasounds and requires careful evaluation to determine its causes, severity, and potential impact on neurological outcomes.
Read More